₹2,700 for a cancer medicine, but an MRP of ₹27,000?
That’s a 10x difference
The issue came up before the Supreme Court during a hearing on cancer drug pricing
If the retailer gets the medicine for ₹2,700, why is the MRP ₹27,000?
The Supreme Court questioned how such a huge price gap can exist for an essential medicine
For a cancer patient, this isn’t just a price tag
It can become a huge financial burden when treatment is already expensive